Stader, F.; Liu, C.; Derbalah, A.; Momiji, H.; Pan, X.; Gardner, I.; Jamei, M.; Sepp, A.
A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes. Antibodies 2024, 13, 70.
https://doi.org/10.3390/antib13030070
AMA Style
Stader F, Liu C, Derbalah A, Momiji H, Pan X, Gardner I, Jamei M, Sepp A.
A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes. Antibodies. 2024; 13(3):70.
https://doi.org/10.3390/antib13030070
Chicago/Turabian Style
Stader, Felix, Cong Liu, Abdallah Derbalah, Hiroshi Momiji, Xian Pan, Iain Gardner, Masoud Jamei, and Armin Sepp.
2024. "A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes" Antibodies 13, no. 3: 70.
https://doi.org/10.3390/antib13030070
APA Style
Stader, F., Liu, C., Derbalah, A., Momiji, H., Pan, X., Gardner, I., Jamei, M., & Sepp, A.
(2024). A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes. Antibodies, 13(3), 70.
https://doi.org/10.3390/antib13030070
